Distribution of ten laminin chains in dystrophic and regenerating muscles

Neuromuscular Disorders

Volumn 9, Issue 6-7, 1999, Pages 423-433

  Patton, Bruce L ^a   Connolly, Anne M ^a,b   Martin, Paul T ^a   Cunningham, Jeanette M ^a   Mehta, Shobhna ^a   Pestronk, Alan ^a   Miner, Jeffrey H ^a   Sanes, Joshua R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

Laminin chains, distribution, dystrophic muscle; Regenerating muscle

Indexed keywords

LAMININ;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; EMERY DREIFUSS MUSCULAR DYSTROPHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; LIMB GIRDLE MUSCULAR DYSTROPHY; MOUSE; MUSCLE CELL; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; NEWBORN; NONHUMAN; NORMAL HUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN VARIANT;

ADOLESCENT; ADULT; ANIMALS; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; LAMININ; MICE; MIDDLE AGED; MUSCLE DENERVATION; MUSCLE FIBERS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; MUSCULAR DYSTROPHY, DUCHENNE; MUSCULAR DYSTROPHY, EMERY-DREIFUSS; REGENERATION;

EID: 0032832468     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(99)00033-4     Document Type: Article

References (71)

1. Engvall E., Wewer U.M. Domains of laminin. J Cell Biochem. 61:1996;493-501.
2. Miner J.H., Patton B.L., Lentz S.I., et al. The laminin α chains: expression, developmental transitions, and chromosomal locations of α1-5, identification of hetrotrimeric laminins 8-11, and cloning of a novel α3 isoform. J Cell Biol. 137:1997;701.
3. Ehrig K., Leivo I., Argraves W.S., Rouslahti E., Engvall E., Merosin a tissue-specific basement membrane protein. , is a laminin-like protein. Proc Nat Acad Sci (USA). 87:1990;3264-3268.
4. Engvall E., Earwicker D., Haaparanta T., Ruoslahti E., Sanes J.R. Distribution and isolation of four laminin variants; tissue restricted distribution of heterotrimers assembled from five different subunits. Cell Regul. 1:1990;731-740.
5. Sanes J.R., Engvall E., Butkowski R., Hunter D.D. Molecular heterogeneity of basal laminae: isoforms of laminin and collagen IV at the neuromuscular junction and elsewhere. J Cell Biol. 111:1990;1685-1699.
6. Burgeson R.E., Chiquet M., Deutzmann R., et al. A new nomenclature for laminins. Matrix Biol. 14:1994;209-211.
7. Sanes J.R. The extracellular matrix. Engel A.G., Franzini-Armstrong C. Myology. 2:1994;242 McGraw-Hill, New York.
8. Vachon P.H., Loechel F., Xu H., Wewer U.M., Engvall E. Merosin and laminin in myogenesis: specific requirement for merosin in myotube stability and survival. J Cell Biol. 134:1996;1483-1497.
9. Straub V., Campbell K.P. Muscular dystrophies and the dystrophin-glycoprotein complex. Curr Opin Neurol. 10:1997;168-175.
10. Mayer U., Saher G., Fassler R. Absence of integrin α7 causes a novel form of muscular dystrophy. Nat Genet. 17:1997;318-323.
11. Hayashi Y.K., Chou F.L., Engvall E. Mutations in the integrin α7 gene cause congenital myopathy. Nat Genet. 19:1998;94-97.
12. Arahata K., Hayashi Y.K., Koga R., et al. Laminin in animal models for muscular dystrophy: defect of laminin-M in skeletal and cardiac muscles and peripheral nerve of the homozygous dystrophic dy/dy mice. Proc Jap Acad Biol. 69:1993;259-264.
13. Xu H., Wu X.R., Wewer U.M. Engvall E., Murine muscular dystrophy caused by a mutation in the laminin α2 (Lama2) gene. Nat Genet. 8:1994;297-302.
14. Sunada Y., Bernier S.M., Kozak C.A., Yamada Y., Campbell K.P. Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain gene to dy locus. J Biol Chem. 269:1994;13729-13732.
15. Tome F.M., Evangelista T., Leclerc A., Sunada Y., Manole E., Estournet B., Barois A., Campbell K.P., Fardeau M. Congenital muscular dystrophy with merosin deficiency. C R Acad Sci (Paris) Sciences de la vie/Life Sci. 317:1994;351-357.
16. Helbling-Leclerc A., Zhang X., Topaloglu H., et al. Mutations in the laminin α-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet. 11:1995;216-218.
17. Miyagoe Y., Hanaoka K., Nonaka I., et al. Laminin α2 chain-null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin 2)-deficient congenital muscular dystrophy. FEBS Lett 415:1997;33-39.
18. Muntoni F., Sewry C.A. Congenital muscular dystrophy: from rags to riches. Neurology. 51:1998;14-17.
19. Pegoraro E., Marks H., Garcia C.A., et al. Laminin α2 muscular dystrophy. Neurology. 51:1998;101-109.
20. Kuang W., Xu H., Vachon P.H., et al. Merosin-deficient congenital muscular dystrophy: partial genetic correction in two mouse models. J Clin Invest. 102:1998;844-852.
21. Hayashi Y.K., Engvall E., Arikawa-Hirasawa E., et al. Abnormal localization of laminin subunits in muscular dystrophies. J Neurol Sci. 119:1993;53-64.
22. Higuchi I., Yamada H., Fukunaga H., et al. Abnormal expression of laminin suggests disturbance of sarcolemma-extracellular matrix interaction in Japanese patients with autosomal recessive muscular dystrophy deficient in adhalin. J Clin Invest. 94:1994;601-606.
23. Sewry C.A., Philpot J., Mahony D., et al. Expression of laminin subunits in congenital muscular dystrophy. Neuromusc Disord. 5:1995;307-316.
24. Yamada H., Tome F.M., Higuchi I., et al. Laminin abnormality in severe childhood autosomal recessive muscular dystrophy. Lab Invest. 72:1995;715-722.
25. Mundegar R.R., von Oertzen J., Zierz S. Increased laminin A expression in regenerating myofibers in neuromuscular disorders. Muscle Nerve. 18:1995;992-999.
26. Wewer U.M., Durkin M.E., Zhang X. Laminin α-2 chain and adhalin deficiency in the skeletal muscle of Walker-Warburg syndrome (cerebro-ocular dysplasia-muscular dystrophy). Neurology. 45:1995;2099-2101.
27. Connolly A.M., Pestronk A., Planer G.J., et al. Congenital muscular dystrophy syndromes distinguished by alkaline and acid phosphatase, merosin, and dystrophin staining. Neurology. 46:1996;810-814.
28. Morandi L., Barresi R., DiBlasi C., et al. Clinical heterogeneity of adhalin deficiency. Ann Neurol. 39:1996;196-202.
29. Cohn R.D., Herrmann R., Wewer U.M., Voit T. Changes of laminin α2 chain expression in congenital muscular dystrophy. Neuromusc Disord. 7:1997;373-378.
30. Li M., Dickson D.W., Spiro A.J. Abnormal expression of laminin b1 chain in skeletal muscle of adult-onset limb-girdle muscular dystrophy. Arch Neurol. 54:1997;1457-1461.
31. Taylor J., Muntoni F., Robb S., Dubowitz V., Sewry C. Early onset autosomal dominant myopathy with rigidity of the spine-a possible role for laminin (1. Neuromusc Disord. 7:1997;211-216.
32. Tiger C.-F., Champliaud M.F., Pedrosa-Domellof F., et al. Presence of laminin α5 chain and lack of laminin α1 chain during human muscle development and in muscular dystrophies. J Biol Chem. 272:1997;28590-28595.
33. Cohn R.D., Herrmann R., Sorokin L., Wewer U.M., Voit T. Laminin α2 chain-deficient congenital muscular dystrophy. Neurology. 51:1998;94-100.
34. Carter W.G., Ryan M.C., Gahr P.J., Epiligrin a new cell adhesion lig. for integrin α3β1 in epithelial basement membranes. Cell. 65:1991;599-610.
35. Rousselle P., Lunstrum G.P., Keene D.R., Burgeson R.E. Kalinin: an epithelium-specific basement membrane adhesion molecule that is a component of anchoring filaments. J Cell Biol. 114:1991;567-576.
36. Aberdam M.D., Aguzzi A., Baudoin C. Developmental expression of nicein adhesion protein (laminin-5) subunits suggests multiple morphogenic roles. Cell Adhes Commun. 2:1994;115-119.
37. Richards A.J. Al-Imara, L., Carter, N.P., Localization of the gene (LAMA4) to chromosome 6q21 and isolation of a partial cDNA encoding a variant laminin A chain. Genomics. 22:1994;237-239.
38. Iivanainen A., Sainio K., Sariola H., Tryggvason K. Primary structure and expression of a novel human laminin α4 chain. FEBS Lett. 365:1995;183-188.
39. Patton B.L., Miner J.H., Chiu A.Y., Sanes J.R. Distribution and function of laminins in the neuromuscular system of developing, adult and mutant mice. J Cell Biol. 139:1997;1507-1521.
40. Tsuchiya Y., Arahata K. Emery-Dreifuss syndrome. Curr Opin Neurol. 10:1997;421-425.
41. Bione S., Maestrini E., Rivella S., Mancini M., Regis S., Romeo G., Toniolo D. Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy. Nat Genet. 8:1994;323-327.
42. Nagano A., Koga R., Ogawa M., et al. Emerin deficiency at the nuclear membrane in patients with Emery-Dreifuss muscular dystrophy. Nat Genet. 12:1996;254-259.
43. Connolly A.M., Pestronk A., Mehta S. Al-Lozi, M., Primary α-sarcoglycan deficiency responsive to immunosuppression over three years. Muscle Nerve. 1998;in press.
44. Duggan D.J., Gorospe R., Fanin M.S., et al. Mutations in the sarcoglycan genes in patients with myopathy. N Engl J Med. 336:1997;618-624.
45. Grady R.M., Teng H., Nichol M.C., et al. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell. 90:1997;729-738.
46. Brooke M.H., Kaiser K.K. Three 'myosin adenosine triphosphatase' systems: the nature of their pH lability and sulfhydryl dependence. J Histochem Cytochem. 18:1970;670-672.
47. Sheehan D.C., Hrapchak B.B. Enzyme histochemistry. Institute B.M. Theory and Practice of Histotechnology. 1987;292 Battelle Press, Columbus, Ohio.
48. Nicholson L.V.B., Davison K., Johnson M.A. Immunoreactivity in patients with Xp21 muscular dystrophy. J Neurol Sci. 94:1989;137-146.
49. Nissinen M., Vuolteenaho R., Boot-Handford R., Kallunki P., Tryggvason K. Primary structures of the human laminin A chain: limited expression in human tissues. Biochem J. 276:1991;369-379.
50. Rambukkana A., Salzer J.L., Yurchenco P.D., Tuomanen E.I. Neural targeting of mycobacterium leprae mediated by the G domain of the laminin-α2 chain. Cell. 88:1997;811-821.
51. Hunter D.D., Shah V., Merlie J.P. Sanes J.R., Laminin-like adhesive protein concentrated in the synaptic cleft of the neuromuscular junction. Nature. 338:1989;229-234.
52. Tiger C.-F., Gullberg D. Absence of laminin α1 chain in the skeletal muscle of dystrophic dy/dy mice. Muscle Nerve. 20:1997;1515-1524.
53. Sorokin L.M., Conzelmann S., Ekblom P., et al. Monoclonal antibodies against laminin A chain fragment E3 and their effects on binding to cells and proteoglycan and on kidney development. Exp Cell Res. 201:1992;137-144.
54. Abrahamson D.R., Irwin M.H., St. John P.L., et al. Selective immunoreactivities of kidney basement membranes to monoclonal antibodies against laminin: localization of the end of the long arm and the short arms to discrete microdomains. J Cell Biol. 109:1989;3477-3491.
55. Martin P.T., Ettinger A.J., Sanes J.R. A synaptic localization domain in the synaptic cleft protein laminin β2 (s-laminin). Science. 269:1995;413-416.
56. Allamand V., Sunada Y., Salih M.A., et al. Mild congenital muscular dystrophy in two patients with an internally deleted laminin α2 chain. Hum Mol Genet. 6:1997;747-752.
57. Sewry C.A., Naom I., et al. D'Alessandro, M., Variable clinical phenotype in merosin-deficient congenital muscular dystrophy associated with differential immunolabelling of two fragments of the laminin α2 chain. Neuromusc Disord. 5:1995;307-316.
58. Sorokin L.M., Pausch F., et al. Frieser M., Developmental regulation of the laminin α5 chain suggests a role in epithelial and endothelial cell maturation. Dev Biol. 189:1997;285-300.
59. Sartore S., Gorza L., Schiaffino S. Fetal myosin heavy chains in regenerating muscle. Nature. 298:1982;294-296.
60. Bischoff R. The satellite cell and muscle regeneration. Engel A.G., Franzini-Armstrong C. Myology. 1:1994;97 McGraw-Hill, New York.
61. Carlson B.M., Gutmann E. Regeneration in free grafts of normal and denervated muscles in the rat: morphology and histochemistry. Anat Rec. 183:1975;47-62.
62. Carlson B.M. Muscle regeneration and aging. Monogr Dev Biol. 23:1992;189-195.
63. Deconinck A.E., Rafael J.A., Skinner J.A. Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell. 90:1997;717-727.
64. Sewry C.A., Chevallay M., Tome F.M.S. Expression of laminin subunits in human fetal skeletal muscle. Histochem J. 27:1995;497-504.
65. Schiaffino S., Gorza L., Dones I., Cornelio F., Sartore S. Fetal myosin immunoreactivity in human dystrophic muscle. Muscle Nerve. 9:1986;51-58.
66. Webster C., Silberstein L., Hays A.P., Blau H.M. Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy. Cell. 52:1988;503-513.
67. Marini J.F., Pons F., Leger J., Loffreda N., Anoal M., Chevallay M., Fardeau M., Leger J.J. Expression of myosin heavy chain isoforms in Duchenne muscular dystrophy patients and carriers. Neuromusc Disord. 1:1991;397-409.
68. Straub V., Rafael J.A., Chamberlain J.S., Campbell K.P. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J Cell Biol. 139:1997;375-385.
69. Moghadaszadeh B., Desguerre I., Topaloglu H., et al. Identification of a new locus for a peculiar form of congenital muscular dystrophy with early rigidity of the spine, on chromosome IP35-36. Am J Hum Genet. 62:1998;1439-1445.
70. Sieb J.P., Dorfler P., Tzartos S., Wewer U.M., Ruegg M.A., Meyer D., Baumann I., Lindemuth R., Jakschik J., Ries F. Congenital myasthenic syndromes in two kinships with end-plate acetylcholine receptor and utrophin deficiency. Neurology. 50:1998;54-61.
71. Cho S.I., Ko J., Patton B.L., Sanes J.R., Chiu A.Y. Motor neurons and Schwann cells distinguish between synaptic and extrasynaptic isoforms of laminin. J Neurobiol. 37:1998;339-358.